• OPEN AN ACCOUNT
Indian Indices
Nifty
24,500.90 -211.15
(-0.85%)
Sensex
79,809.65 -270.92
( -0.34%)
Bank Nifty
53,820.35 -630.10
( -1.16%)
Nifty IT
35,488.80 -574.40
( -1.59%)
Global Indices
Nasdaq
45,661.67 75.43
(0.17%)
Dow Jones
6,523.31 20.91
(0.32%)
Hang Seng
42,764.54 -64.25
(-0.15%)
Nikkei 225
9,216.82 -38.68
(-0.42%)
Forex
USD-INR
87.60 -0.05
(-0.06%)
EUR-INR
102.16 0.14
(0.13%)
GBP-INR
118.33 0.25
(0.21%)
JPY-INR
0.60 0.00
(0.24%)

EQUITY - MARKET SCREENER

Makers Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
506919
INE987A01010
95.0369536
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
15.53
86.79
EPS(TTM)
Face Value()
Div & Yield %
9.47
10
0
 

B. L. Kashyap and Sons gains after securing Rs 910-cr order from BPTP
Jul 22,2025
The scope of work includes construction of civil structures for residential towers, along with associated non-tower areas, community buildings, etc. The project is to be executed over a period of 36 months.

B. L. Kashyap and Sons is an EPC company engaged in the business of Construction of high-rise residential and Commercial Complexes, IT Parks, Institutional Buildings, etc.

The company reported a net loss of Rs 3.26 crore in Q4 FY25, compared with a net profit of Rs 23.66 crore in Q1 FY24. Revenue from operations fell 13.8% YoY to Rs 294.18 crore in Q4 FY25, from Rs 341.18 crore in the corresponding quarter of the previous year.